Anethole blocks both early and late cellular responses transduced by tumor necrosis factor:: effect on NF-κB, AP-1, JNK, MAPKK and apoptosis

被引:167
作者
Chainy, GBN [1 ]
Manna, SK [1 ]
Chaturvedi, MM [1 ]
Aggarwal, BB [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Cytokine Res Lab, Houston, TX 77030 USA
关键词
anethole; TNF; NF-kappa B; AP-1; JNK; apoptosis;
D O I
10.1038/sj.onc.1203614
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anethole, a chief constituent of anise, camphor, and fennel, has been shown to block both inflammation and carcinogenesis, but just how these effects are mediated is not known, One possibility is TNF-mediated signaling, which has also been associated with both inflammation and carcinogenesis. In the present report we show that anethole is a potent inhibitor of TNF-induced NF-kappa B activation (an early response) as monitored by electrophoretic mobility shift assay I kappa B alpha phosphorylation and degradation, and NF-kappa B reporter gene expression. Suppresaon of I kappa B alpha phosphorylation and NF-kappa B reporter gene expression induced by TRAF2 and NIK, suggests that anethole acts on I kappa B alpha kinase, Anethole also blocked the NF-kappa B activation induced by a variety of other inflammatory agents. Besides NF-kappa B, anethole also suppressed TNF-induced activation of the transcription factor AP-1, c-jun N-terminal kinase and MAPK-kinase, In addition, anethole abrogated TNF-induced apoptosis as measured by both caspase activation and cell viability. The anethole analogues eugenol and isoeugenol also blocked TNF signaling. Anethole suppressed TNF-induced both lipid peroxidation and ROI generation. Overall, our results demonstrate that anethole inhibits TNF-induced cellular responses,,which mag explain its role in suppression of inflammation and carcinogenesis.
引用
收藏
页码:2943 / 2950
页数:8
相关论文
共 40 条
[1]  
Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93
[2]   INFLUENCE OF ANETHOLE TREATMENT ON THE TUMOR-INDUCED BY EHRLICH ASCITES-CARCINOMA CELLS IN PAW OF SWISS ALBINO MICE [J].
ALHARBI, MM ;
QURESHI, S ;
RAZA, M ;
AHMED, MM ;
GIANGRECO, AB ;
SHAH, AH .
EUROPEAN JOURNAL OF CANCER PREVENTION, 1995, 4 (04) :307-318
[3]   NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules [J].
Baeuerle, PA ;
Baichwal, VR .
ADVANCES IN IMMUNOLOGY, VOL 65, 1997, 65 :111-137
[4]   Assessment of the role of glutathione conjugation in the protection afforded by anethol dithiolthione against hexachloro-1,3-butadiene-induced nephrotoxicity [J].
Bouthillier, L ;
Charbonneau, M ;
Brodeur, J .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 139 (01) :177-185
[5]   Lipid peroxidation is involved in the activation of NF-kappa B by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304 - Lack of involvement of H2O2 in NF-kappa B activation by either cytokine in both primary and transformed endothelial cells [J].
Bowie, AG ;
Moynagh, PN ;
ONeill, LAJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25941-25950
[6]  
Budavari S., 1996, MERCK INDEX, P108
[7]   Sanguinarine (pseudochelerythrine) is a potent inhibitor of NP-kappa B activation, I kappa B alpha phosphorylation, and degradation [J].
Chaturvedi, MM ;
Kumar, A ;
Darnay, BG ;
Chainy, GBN ;
Agarwal, S ;
Aggarwal, BB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30129-30134
[8]   Characterization of the intracellular domain of receptor activator of NF-κB (RANK) -: Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase [J].
Darnay, BG ;
Haridas, V ;
Ni, J ;
Moore, PA ;
Aggarwal, BB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20551-20555
[9]   Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase -: Identification of a novel TRAF6 interaction motif [J].
Darnay, BG ;
Ni, J ;
Moore, PA ;
Aggarwal, BB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :7724-7731
[10]   Anethole dithiolethione prevents oxidative damage in glutathione-depleted astrocytes [J].
Drukarch, B ;
Schepens, E ;
Stoof, JC ;
Langeveld, CH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 329 (2-3) :259-262